Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Valproic acid is an effective seizure medication with some temporary side effects.

Progesterone and its metabolites can prevent seizures without major side effects.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Blocking progesterone metabolism can cause depression-like behavior in mice.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Trazodone might help reverse post finasteride syndrome.

A 5-year-old girl with McCune-Albright syndrome grew abnormal hair due to the drug tamoxifen.

Flutamide treatment showed no significant changes in mice vaginal mucosa.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

Topical flutamide works as well as hydroquinone for melasma but needs more safety checks.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Topical finasteride may help treat facial hirsutism in women.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.